Health insurance benefit limits: General concepts and the potential impact on dermatologic treatment

Journal of the American Academy of Dermatology

Volumn 53, Issue 1, 2005, Pages 140-142

  Venkat, Arun P ^a   Scheinfeld, Noah S ^b   Kulkarni, Amit S ^c   Balkrishnan, Rajesh ^c   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEFACEPT; CYCLOSPORIN; DERMATOLOGICAL AGENT; EFALIZUMAB; ETANERCEPT; ETRETIN; IMMUNOLOGIC AGENT; INFLIXIMAB; ISOTRETINOIN; METHOTREXATE; PSORALEN;

ARTICLE; DERMATOLOGY; DRUG CHOICE; DRUG COST; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH INSURANCE; MEDICARE; PRIORITY JOURNAL; PSORIASIS;

ADOLESCENT; ADULT; CHILD; DERMATOLOGY; HUMANS; INSURANCE BENEFITS; INSURANCE, HEALTH; MIDDLE AGED; SKIN DISEASES;

EID: 20444438228     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.11.032     Document Type: Article

References (18)

1. L.M. Litton, F.A. Sisk, and M.E. Akins Managing drug costs: the perception of managed care pharmacy directors Am J Manag Care 6 2000 805 814
2. A. Lyles, and F.B. Palumbo The effect of managed care on prescription drug costs and benefits Pharmacoeconomics 12 1999 129 140
3. D.E. Joranson Are health-care reimbursement policies a barrier to acute and cancer pain management? J Pain Symptom Manage 9 1994 244 253
4. Supreme Court leaves intact ruling permitting AIDS caps AIDS Policy Law 15 2000 1,6
5. C.W. Tseng, R.H. Brook, E. Keeler, and C.M. Mangione Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients JAMA 290 2003 222 227
6. Barry P. Forces gather to push for change in new Medicare drug benefit. AARP Bulletin Online March 2004. Available from: http://www.aarp.org/bulletin/ prescription/Articles/a2004-03-10-forces.html. Accessed September 30, 2004.
7. Trend of the month: HMOs continue to struggle with higher Rx costs and utilization Drug Benefit Trends 12 2000 7 8
8. S.L. Mehlis, and K.B. Gordon The immunology of psoriasis and biologic immunotherapy J Am Acad Dermatol 49 Suppl 2003 S44 S50
9. Healthcare insurance in the United States. Euromonitor: Major Market Profiles 2003;9:1-9.
10. Personal advantage program benefits. Kaiser Permanente World Wide Web site. Available from: http://ckp.kp.org/locations/california/individuals/ personaladv/paBenefits.htm. Accessed February 12, 2004.
11. Blue advantage. Blue Cross Blue Shield of North Carolina World Wide Web site. Available from: http://www.bcbsnc.com/plans/blueadvantage/summary.cfm. Accessed February 12, 2004.
12. Drug Topics Red Book. Oradell (NJ): Medical Economics Company; 2004.
13. S.H. Zuvekas, and G.S. Taliaferro Pathways to access: health insurance, the health care delivery system, and racial/ethnic disparities, 1996-1999 Health Aff (Millwood) 22 2003 139 153
14. A. Davidoff, L. Dubay, G. Kenny, and A. Yemane The effect of parents' insurance coverage on access to care for low-income children Inquiry 40 2003 254 268
15. K.V. Nair, P. Wolfe, R.J. Valuck, M.M. McCollum, J.M. Ganther, and S.J. Lewis Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease J Manag Care Pharm 9 2003 123 133
16. M. Lebwohl, and S. Ali Treatment of psoriasis: part 1, topical therapy and phototherapy J Am Acad Dermatol 45 2001 487 498
17. M. Lebwohl, and S. Ali Treatment of psoriasis: part 2, systemic therapies J Am Acad Dermatol 45 2001 649 661
18. 2004-2005 Health insurance at Columbia guide. Available from: http://www.health.columbia.edu/ins/index.html. Accessed September 30, 2004.